无论诱导阶段是否曾使用过利妥昔单抗维持治疗均可改善复发/难治滤泡性淋巴瘤临床预后Ⅲ期随机对照研究的评价

摘要

@@ 1 文献类型rn治疗.rn2 证据水平rn1b.rn3 文献来源rnOers MHJ, Klasa R, Marcus RE, et al.Rituximab maintenance improves clinical outcome of relapsed/resistant follicular non-Hodgkin's lymphoma,both in patients with and without rituximab during induction: results of a prospective randomized phase Ⅲ intergroup trial [J]. Blood, 2006,108(10):3295-3301.